[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-377722-105":59,"doc-detail-377722-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","recurrent-reversible-stroke-like-encephalopathy-after-5-fluorouracil-5-fu-chemotherapy-a-case-report-and-literature-review","Recurrent Reversible Stroke-Like Encephalopathy After 5-Fluorouracil (5-FU) Chemotherapy - A Case Report and Literature Review","","Recurrent, reversible stroke-like encephalopathy developed after high-dose 5-fluorouracil (5-FU) chemotherapy in a 49-year-old man with stage IV colorectal cancer. Severe encephalopathy occurred during the seventh through ninth cycles of a FOLFIRI regimen and was linked to a 46-hour continuous intravenous 5-FU infusion. Symptoms began shortly after infusion and resolved within 24 hours. The case highlights 5-FU-induced hyperammonemic encephalopathy as a rare but serious, potentially recurrent adverse event requiring immediate infusion cessation, supportive fluids, and close monitoring.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/recurrent-reversible-stroke-like-encephalopathy-after-5-fluorouracil-5-fu-chemotherapy-a-case-report-and-literature-review/377722/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/recurrent-reversible-stroke-like-encephalopathy-after-5-fluorouracil-5-fu-chemotherapy-a-case-report-and-literature-review/377722.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-24",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What caused the patient’s stroke-like encephalopathy after chemotherapy?","Question",{"text":113,"@type":114},"The encephalopathy was attributed to 5-FU-induced hyperammonemic neurotoxicity associated with the 46-hour continuous intravenous 5-FU infusion used in the FOLFIRI regimen.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the condition recognized and managed in the report?",{"text":118,"@type":114},"Immediate recognition was emphasized; the first management step is to stop the 5-FU infusion and provide high volumes of fluid to support recovery.",{"name":120,"@type":111,"acceptedAnswer":121},"Can the encephalopathy recur if 5-FU is re-administered?",{"text":122,"@type":114},"Yes. Although many cases resolve spontaneously, recurrence is possible if the same patient receives the drug again, so close monitoring for signs and symptoms is crucial.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},377722,1790246321,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","e-ISSN 1941-5923  \n© Am J Case Rep, 2023; 24: e938437 DOI: 10. 12659/AJCR.938437  \nReceived: 2022.09.20  \nAccepted: 2023.02.14  \nAvailable online: 2023.03.01  \nPublished: 2023.04.04  \nAuthors’ Contribution: Study Design A  \nData Collection B Statistical Analysis C Data Interpretation D Manuscript Preparation E Literature Search F Funds Collection G  \nABCDEF 1  \nABCD 1  \nBD 2 BDEF 1,3  \nCorresponding Author: Financial support: Conflict of interest:  \nRecurrent Reversible Stroke-Like Encephalopathy After 5-Fluorouracil (5-FU) Chemotherapy: A Case Report and Literature Review  \nKurniawan Agung Yuwono Susanna Hilda Hutajulu  Abdul Gofir   \nDhite Bayu Nugroho  \n1 Department of Internal Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia  \n2 Department of Neurology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia  \n3 Clinical Epidemiology and Biostatistics Unit, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia  \nDhite Bayu Nugroho, e-mail: [dhite@ugm.ac.id](dhite@ugm.ac.id)[ ](dhite@ugm.ac.id)None declared  \nNone declared  \nPatient: Male, 49-year-old  \nFinal Diagnosis: Colorectal cancer  \nSymptoms: Hemiparesis • unconsciousness  \nClinical Procedure: —  \nSpecialty: Oncology  \nObjective: Unusual clinical course  \nBackground: Chemotherapy based on 5-fluorouracil (5-FU) is a well-established treatment for solid cancers, including metastatic or advanced colon cancer. Despite its efficacy, 5-FU can cause rare but serious adverse events such as acute neurotoxicity, which presents as symptoms similar to stroke.  \nCase Report: We report the case of a patient who was diagnosed with stage IV colorectal cancer and who underwent chemotherapy with a high dose of 5-FU as part of the FOLFIRI (Folinic Acid, Fluorouracil, Irinotecan) treatment plan. During the seventh, eighth, and ninth cycles of chemotherapy, the patient suffered from severe encephalopathy, and the cause of this condition was determined to the 46-hour continuous intravenous infusion of 5-FU, which was part of the FOLFIRI regimen.  \nConclusions: 5-FU-induced hyperammonemic encephalopathy is a rare but serious adverse event that requires immediate recognition and treatment. The first step in managing this condition is to halt the 5-FU infusion and provide the patient with high volumes of fluid. Although most cases of 5-FU-induced encephalopathy resolve spontaneously, recurrence is possible if the drug is re-administered to the same patient. Therefore, it is crucial for healthcare providers to closely monitor patients receiving 5-FU chemotherapy and be aware of the signs and symptoms of hyperammonemic encephalopathy. Early intervention can prevent further complications and ensure the best possible outcome for the patient.  \nIt is important to note that while 5-FU-induced hyperammonemic encephalopathy is rare, it highlights the importance of closely monitoring patients receiving chemotherapy to identify and treat adverse events promptly. This can help improve patient outcomes and prevent serious long-term complications.  \nKeywords: Colorectal Neoplasms • IFL Protocol • Ischemic Stroke  \nFull-text PDF: [https://www.amjcaserep.com/abstract/index/idArt/938437](https://www.amjcaserep.com/abstract/index/idArt/938437)  \n1744  3  4  16  \nPublisher’s note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher  \nThis work is licensed under Creative Common AttributionNonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)  \ne938437-1  \nIndexed in: [PMC] [PubMed] [Emerging Sources Citation Index (ESCI)][Web of Science by Clarivate]  \nYuwono [K.A. et](K.A. et","cbCaifE3vHAikjtl","https://ap.wps.com/l/cbCaifE3vHAikjtl","pdf",1367234,"English","# Background\n# Case Report\n## Patient history and prior treatments\n## Neurologic presentation and course\n# Conclusions\n# Keywords","[{\"question\":\"What caused the patient’s stroke-like encephalopathy after chemotherapy?\",\"answer\":\"The encephalopathy was attributed to 5-FU-induced hyperammonemic neurotoxicity associated with the 46-hour continuous intravenous 5-FU infusion used in the FOLFIRI regimen.\"},{\"question\":\"How was the condition recognized and managed in the report?\",\"answer\":\"Immediate recognition was emphasized; the first management step is to stop the 5-FU infusion and provide high volumes of fluid to support recovery.\"},{\"question\":\"Can the encephalopathy recur if 5-FU is re-administered?\",\"answer\":\"Yes. Although many cases resolve spontaneously, recurrence is possible if the same patient receives the drug again, so close monitoring for signs and symptoms is crucial.\"}]","Recurrent Reversible Stroke-Like Encephalopathy After 5-Fluorouracil (5-FU) Chemotherapy - A Case Report and Literature Review | PDF",1790226851,18]